Methods of and compositions for reducing neuronal cell death

Details Methods of and compositions for reducing neuronal cell death Methods of and compositions for reducing neuronal cell death

2011-04-26

2011-04-26

Padmanabhan, Sreeni (Department: 1627)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Boron containing doai

C514S075000, C514S120000, C568S002000, C568S006000, C568S008000, C568S013000, C568S017000

Reexamination Certificate

active

07932239

ABSTRACT:
Methods and compositions involving a class of boron-protected phenylphosphine agents having increased cell permeability and having improved chemical stability for treating or for preventing neuronal cell death-related diseases or conditions in a human or a non-human animal.

REFERENCES:
patent: 6706926 (2004-03-01), Brown et al.
Imamoto et al. 1990, Synthesis and Reactions of phosphine-boranes. J. Am. Chem. Soc. vol. 112, pp. 5244-5252.
Gourdel et al. 1993, Activation of Phosphines with borane. Tetrahedron Letters, vol. 34, No. 6, pp. 1011-1012.
Leautey et al. 2001, Synthesis of alpha-substituted beta-amidophosphines by diastereoselective alkylation. J. Org. Chem. vol. 66, No. 16, pp. 5566-5571.
Cheng C, et al., “Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis,” Invest. Opthalmol. Vis. Sci. 36:442-453 (1995).
Chetoni P, et al., “Ocular mini-tablets for controlled release of timolol: evaluation in rabbits,” J. Ocul. Pharmacol. Ther. 129:245-252 (1996).
Feist R, et al., “Effectiveness of apraclonidine and acetazolamide in preventing postoperative intraocular pressure spikes after extracapsular cataract extraction,” J. Cataract Refract. Surg. 21:191-195 (1995).
Geiger L, et al., “Reduced redox state allows prolonged survival of axotomized neonatal retinal ganglion cells,” Neuroscience 109:635-642 (2002).
Imamoto T, et al., “Phosphine oxides and lithium aluminum hydride-sodium borohydride-cerium(III) chloride: synthesis and reactions of phosphine-boranes” J. Am. Chem. Soc. 107:5301-5303 (1985).
Imamoto T, “Synthesis and reactions of new phospine-boranes,” Pure & Appl.Chem. 65:655-660 (1993).
Joshi A, “Microparticulates for ophthalmic drug delivery,” J. Ocul. Pharmacol. 10:29-45 (1994).
Levkovitch-Verbin H, et al., “Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats,” Invest. Ophthalmol. Vis. Sci. 43:402-410 (2002).
McCalden T & Levy M, “Retention of topical liposomal formulations on the cornea,” Experientia 46:713-715 (1990).
Meseguer G, et al., “Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers,” J. Ocular. Pharm. Ther. 12:481-488 (1996).
Nelson M, et al., “Ocular tolerability of timolol in Gelrite in young glaucoma patients,” J. Am. Optom. Assoc. 67:659-663 (1996).
Rampal J, et al., “Carbon-phosphorus heterocycles. Synthesis and conformational analysis of alkyl-substituted 1,2,6-triphenyl-4-phosphorinanones and derivatives,” J Am. Chem. Soc. 46:1166-1172 (1981).

Affiliated with

Also associated with

Rating

Methods of and compositions for reducing neuronal cell death does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of and compositions for reducing neuronal cell death, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of and compositions for reducing neuronal cell death will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2662783